SCHEMBL7793435

SCHEMBL7793435

CC(=O)NC(CSSCC(NC(C)=O)C(=O)NCCc1ccccc1)C(=O)NCCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.52
CA2 P00918 2/20 0.52
CA9 Q16790 2/20 0.52
CTSS P25774 1/20 0.52
CTSK P43235 1/20 0.52
CA1 P00915 1/20 0.52
CA3 P07451 1/20 0.52
CA4 P22748 1/20 0.52
CA6 P23280 1/20 0.52
CA5A P35218 1/20 0.52
CA7 P43166 1/20 0.52
CACNA1C Q13936 1/20 0.52
SCN9A Q15858 1/20 0.52
CA13 Q8N1Q1 1/20 0.52
CA14 Q9ULX7 1/20 0.52
CA5B Q9Y2D0 1/20 0.52
POLB P06746 1/20 0.51
ANPEP P15144 1/20 0.49
KMT2A Q03164 3/20 0.49
MEN1 O00255 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7799262 0.86 POLB (0.52) CA12CA2CA9POLBANPEP
SCHEMBL7793390 0.85 KMT2A (0.57) CA12CA2CA9CTSSCTSK
SCHEMBL7798889 0.82 NPC1 (0.64) CTSSCTSKPOLBKMT2AMMP8
SCHEMBL26292543 0.82 ITGB3 (0.52) CA12CA2CA9CTSSCTSK
SCHEMBL7802323 0.81 ITGB3 (0.54) HPGD
SCHEMBL7793406 0.81 POLB (0.49) CA12CA2CA9CA1CA5A
SCHEMBL7798914 0.81 POLB (0.48) CA12CA2CA9POLBKMT2A
SCHEMBL7803203 0.80 POLB (0.51) CA2CA1CA5APOLBANPEP
SCHEMBL4153712 0.80 CTSS (0.62) CTSSCTSKKMT2AMMP8
SCHEMBL13819246 0.80 CTSS (0.62) CTSSCTSKKMT2AMMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1143960-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES Roche Diagnostics GmbH (DE) 2001-10-17 EP disclosed
WO-2000027378-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES ROCHE DIAGNOSTICS GMBH (DE) 2000-05-18 WO disclosed